/ Dr.Reddy’s Up 2% In USFDA Report For Miryalaguda Unit ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 14 June 2017

On Wednesday Dr. Reddy’s Laboratories share gained 2% after the establishment inspection report from the USFDA health regulator for its Miryalaguda Plant. The company said in its filling that they have received establishment inspection report (EIR) from USFDA for their active pharmaceutical plant at Miryalaguda indicating the successful closure of the agency’s audit. USFDA inspected plants from February 13-21, received form 483 with 3 observations.

The Miryalaguda plant supplies ingredient (active) for company captive consumption and for their customers. On BSE, the stock price was Rs 2,651.50 which is up Rs 23.40 or 0.89%.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔